XML 26 R10.htm IDEA: XBRL DOCUMENT
v3.20.4

Condensed Statements of Changes in Members' Equity (Brooklyn ImmunoTherapeutics, LLC) - USD ($) | Series D Preferred Stock [Member] Brooklyn Immunotherapeutics, LLC [Member] Predecessor [Member] | Series C Preferred Stock [Member] Brooklyn Immunotherapeutics, LLC [Member] Predecessor [Member] | Series B Preferred Stock [Member] Brooklyn Immunotherapeutics, LLC [Member] Predecessor [Member] | Series A Preferred Stock [Member] Brooklyn Immunotherapeutics, LLC [Member] Predecessor [Member] | Common Stock [Member] Brooklyn Immunotherapeutics, LLC [Member] Predecessor [Member] | Common Stock [Member] Brooklyn Immunotherapeutics, LLC [Member] Successor [Member] | Common Stock [Member] | Additional Paid-In Capital [Member] Brooklyn Immunotherapeutics, LLC [Member] Predecessor [Member] | Additional Paid-In Capital [Member] | Subscriptions Receivable, Related Parties [Member] Brooklyn Immunotherapeutics, LLC [Member] Predecessor [Member] | Accumulated Deficit [Member] Brooklyn Immunotherapeutics, LLC [Member] Predecessor [Member] | Accumulated Deficit [Member] Brooklyn Immunotherapeutics, LLC [Member] Successor [Member] | Accumulated Deficit [Member] | Total Stockholder's Deficiency [Member] Brooklyn Immunotherapeutics, LLC [Member] Predecessor [Member] | Total Stockholder's Deficiency [Member] Brooklyn Immunotherapeutics, LLC [Member] Successor [Member] | Total Stockholder's Deficiency [Member] Brooklyn Immunotherapeutics, LLC [Member] | Class A Membership Units [Member] Brooklyn Immunotherapeutics, LLC [Member] Successor [Member] | Class A Membership Units [Member] Brooklyn Immunotherapeutics, LLC [Member] | Class B Membership Units [Member] Brooklyn Immunotherapeutics, LLC [Member] Successor [Member] | Class B Membership Units [Member] Brooklyn Immunotherapeutics, LLC [Member] | Class C Membership Units [Member] Brooklyn Immunotherapeutics, LLC [Member] Successor [Member] | Class C Membership Units [Member] Brooklyn Immunotherapeutics, LLC [Member] | Common Stock [Member] Brooklyn Immunotherapeutics, LLC [Member] | Accumulated Deficit [Member] Brooklyn Immunotherapeutics, LLC [Member] | Brooklyn Immunotherapeutics, LLC [Member] Predecessor [Member] | Brooklyn Immunotherapeutics, LLC [Member] Successor [Member] | Brooklyn Immunotherapeutics, LLC [Member] | Total
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Balance at Dec. 31, 2017 | $ 35,400 | $ 40,461 | $ 35 | $ 141 | $ 7,968 |  | $ 13,000 | $ 179,148,961 | $ 134,752,000 | $ (88,663) | $ (187,130,857) |  | $ (129,119,000) | $ (7,986,554) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5,536,000
Balance, shares at Dec. 31, 2017 | 35,400,669 | 40,460,713 | 35,016 | 140,639 | 7,968,224 |  | 2,521,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon exchange of preferred stock |  | $ (40,461) | $ (35) | $ (141) | $ 16,772 |  |  | (106,536,946) |  |  | 106,560,811 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon exchange of preferred stock, shares |  | (40,460,713) | (35,016) | (140,639) | 16,771,866 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  | (16,098,602) |  |  | (16,098,602) |  |  |  |  |  |  |  |  |  |  | $ (16,098,602) |  |  |
Balance at Nov. 05, 2018 | $ 35,400 |  |  |  | $ 24,740 |  |  | 72,612,015 |  | (88,663) | (96,668,648) |  |  | (24,085,156) | 6,482,005 |  | 6,482,005 |  |  |  |  |  |  |  |  |  |  |
Balance, shares at Nov. 05, 2018 | 35,400,669 |  |  |  | 24,740,090 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at Dec. 31, 2017 | $ 35,400 | $ 40,461 | $ 35 | $ 141 | $ 7,968 |  | $ 13,000 | 179,148,961 | 134,752,000 | (88,663) | (187,130,857) |  | (129,119,000) | (7,986,554) |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,536,000
Balance, shares at Dec. 31, 2017 | 35,400,669 | 40,460,713 | 35,016 | 140,639 | 7,968,224 |  | 2,521,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  | (259,000) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (259,000)
Balance at Dec. 31, 2018 |  |  |  |  |  | 15,248 | $ 14,000 |  | 136,552,000 |  |  | (2,004,472) | (129,394,000) |  | 10,369,706 | 10,369,706 | 9,958,930 | 9,958,930 | 1,400,000 | 1,400,000 | 1,000,000 | 1,000,000 | 15,248 | (2,004,472) |  |  | $ 10,369,706 | 6,917,000
Balance, shares at Dec. 31, 2018 |  |  |  |  |  |  | 2,875,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at Nov. 05, 2018 | $ 35,400 |  |  |  | $ 24,740 |  |  | $ 72,612,015 |  | $ (88,663) | $ (96,668,648) |  |  | $ (24,085,156) | 6,482,005 |  | 6,482,005 |  |  |  |  |  |  |  |  |  |  |
Balance, shares at Nov. 05, 2018 | 35,400,669 |  |  |  | 24,740,090 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation: Amortisation of restricted common unitsof restricted common units |  |  |  |  |  | 15,248 |  |  |  |  |  |  |  |  | 15,248 |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation: Issuance of membership units for purchase of IRX |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,400,000 |  |  |  | 1,400,000 |  | 1,000,000 |  |  |  |  |  |  |
Stock based compensation: Membership units issued in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,000 |  | 5,000 |  |  |  |  |  |  |  |  |  |  |
Stock based compensation: Sale of members' equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,955,579 |  | 1,955,579 |  |  |  |  |  |  |  |  |  |  |
Stock based compensation: Members' equity exchanged for loans payable and interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,516,346 |  | 1,516,346 |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  | (2,004,472) |  |  | (2,004,472) |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at Dec. 31, 2018 |  |  |  |  |  | 15,248 | $ 14,000 |  | 136,552,000 |  |  | (2,004,472) | (129,394,000) |  | 10,369,706 | 10,369,706 | 9,958,930 | 9,958,930 | 1,400,000 | 1,400,000 | 1,000,000 | 1,000,000 | 15,248 | (2,004,472) |  |  | 10,369,706 | 6,917,000
Balance, shares at Dec. 31, 2018 |  |  |  |  |  |  | 2,875,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation: Amortisation of restricted common unitsof restricted common units |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 68,674 |  |  |  |  |  |  | 68,674 |  |  |  |  |
Stock based compensation: Issuance of membership units for purchase of IRX |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation: Membership units issued in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation: Sale of members' equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,395,750 |  | 7,395,750 |  |  |  |  |  |  |  |  |  |
Stock based compensation: Members' equity exchanged for loans payable and interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  | (754,000) |  |  | (6,134,389) |  |  |  |  |  |  |  | (6,134,389) |  |  | (6,134,389) | (754,000)
Balance at Sep. 30, 2019 |  |  |  |  |  |  | $ 14,000 |  | 136,695,000 |  |  |  | (130,156,000) |  |  | 11,699,741 |  | 17,354,680 |  | 1,400,000 |  | 1,000,000 | 83,922 | (8,138,861) |  |  |  | 6,345,000
Balance, shares at Sep. 30, 2019 |  |  |  |  |  |  | 2,895,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at Dec. 31, 2018 |  |  |  |  |  | 15,248 | $ 14,000 |  | 136,552,000 |  |  | (2,004,472) | (129,394,000) |  | 10,369,706 | 10,369,706 | 9,958,930 | 9,958,930 | 1,400,000 | 1,400,000 | 1,000,000 | 1,000,000 | 15,248 | (2,004,472) |  |  | 10,369,706 | 6,917,000
Balance, shares at Dec. 31, 2018 |  |  |  |  |  |  | 2,875,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation: Amortisation of restricted common unitsof restricted common units |  |  |  |  |  | 91,689 |  |  |  |  |  |  |  |  | 91,689 |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation: Sale of members' equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8,218,762 |  | 8,218,762 |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  | (8,937,054) | (2,047,000) |  | (8,937,054) |  |  |  |  |  |  |  |  |  |  | $ (8,937,054) | 8,937,054 | (2,047,000)
Balance at Dec. 31, 2019 |  |  |  |  |  | 106,937 | $ 14,000 |  | 136,721,000 |  |  | (10,941,526) | (131,457,000) |  | 9,743,103 | 9,743,103 | 18,177,692 | 18,177,692 | 1,400,000 | 1,400,000 | 1,000,000 | 1,000,000 | 106,937 | (10,941,526) |  |  | 9,743,103 | 5,091,000
Balance, shares at Dec. 31, 2019 |  |  |  |  |  |  | 2,901,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at Jun. 30, 2019 |  |  |  |  |  |  | $ 14,000 |  | 136,648,000 |  |  |  | (129,805,000) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,667,000
Balance, shares at Jun. 30, 2019 |  |  |  |  |  |  | 2,882,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  | (351,000) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (351,000)
Balance at Sep. 30, 2019 |  |  |  |  |  |  | $ 14,000 |  | 136,695,000 |  |  |  | (130,156,000) |  |  | 11,699,741 |  | 17,354,680 |  | 1,400,000 |  | 1,000,000 | 83,922 | (8,138,861) |  |  |  | 6,345,000
Balance, shares at Sep. 30, 2019 |  |  |  |  |  |  | 2,895,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at Dec. 31, 2019 |  |  |  |  |  | $ 106,937 | $ 14,000 |  | 136,721,000 |  |  | $ (10,941,526) | (131,457,000) |  | $ 9,743,103 | 9,743,103 | $ 18,177,692 | 18,177,692 | $ 1,400,000 | 1,400,000 | $ 1,000,000 | 1,000,000 | 106,937 | (10,941,526) |  |  | 9,743,103 | 5,091,000
Balance, shares at Dec. 31, 2019 |  |  |  |  |  |  | 2,901,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation: Amortisation of restricted common unitsof restricted common units |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 68,202 |  |  |  |  |  |  | 68,202 |  |  |  |  |
Stock based compensation: Sale of members' equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,024,313 |  | 5,024,313 |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  | (4,722,000) |  |  | (5,072,803) |  |  |  |  |  |  |  | (5,072,803) |  |  | (5,072,803) | (4,722,000)
Balance at Sep. 30, 2020 |  |  |  |  |  |  | $ 15,000 |  | 136,881,000 |  |  |  | (136,187,000) |  |  | 9,762,815 |  | 23,202,005 |  | 1,400,000 |  | 1,000,000 | 175,139 | (16,014,329) |  |  | 9,762,815 | 495,000
Balance, shares at Sep. 30, 2020 |  |  |  |  |  |  | 2,952,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at Jun. 30, 2020 |  |  |  |  |  |  | $ 15,000 |  | 136,837,000 |  |  |  | (134,706,000) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,931,000
Balance, shares at Jun. 30, 2020 |  |  |  |  |  |  | 2,938,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  | (1,481,000) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (1,481,000)
Balance at Sep. 30, 2020 |  |  |  |  |  |  | $ 15,000 |  | $ 136,881,000 |  |  |  | $ (136,187,000) |  |  | $ 9,762,815 |  | $ 23,202,005 |  | $ 1,400,000 |  | $ 1,000,000 | $ 175,139 | $ (16,014,329) |  |  | $ 9,762,815 | $ 495,000
Balance, shares at Sep. 30, 2020 |  |  |  |  |  |  | 2,952,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Issuance of common stock upon exchange of preferred stock. + References No definition available. + Details
Name: | NTN_IssuanceOfCommonStockUponExchangeOfPreferredStock
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Issuance of common stock upon exchange of preferred stock, shares. + References No definition available. + Details
Name: | NTN_IssuanceOfCommonStockUponExchangeOfPreferredStockShares
Namespace Prefix: | NTN_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock based compensation: Amortization of restricted common units. + References No definition available. + Details
Name: | NTN_StockBasedCompensationAmortizationOfRestrictedCommonUnits
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Stock based compensation: Issuance of membership units for purchase of IRX. + References No definition available. + Details
Name: | NTN_StockBasedCompensationIssuanceOfMembershipUnitsForPurchaseOfIrx
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Stock based compensation: Members' equity exchanged for loans payable and interest. + References No definition available. + Details
Name: | NTN_StockBasedCompensationMembersEquityExchangedForLoansPayableAndInterest
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Stock based compensation: Membership units issued in exchange for services. + References No definition available. + Details
Name: | NTN_StockBasedCompensationMembershipUnitsIssuedInExchangeForServices
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Stock based compensation: Sale of members' equity. + References No definition available. + Details
Name: | NTN_StockBasedCompensationSaleOfMembersEquity
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227 Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 60B -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares issued which are neither cancelled nor held in the treasury. + References No definition available. + Details
Name: | us-gaap_SharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 4.E) -URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_StockholdersEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant